Cytori Therapeutics reported $8.35M in Cash and Equivalent for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Baxter International BAX:US $ 3730M 629M
Cerus CERS:US $ 36.59M 7.64M
Cytori Therapeutics CYTX:US $ 8.35M 0.72M
Genocea Biosciences GNCA:US $ 79.77M 7.86M
Haemonetics HAE:US $ 189M 90.17M
Infinity Pharmaceuticals INFI:US $ 18.53M 10.39M
Mirati Therapeutics MRTX:US $ 865.16M 752.54M
Starpharma Holdings Ltd SPL:AU 70.27M 40.22M
Sunesis Pharmaceuticals SNSS:US $ 20.41M 5.64M